An intersectional analysis of women's experiences of inclusion in the United States Army

Abstract: In 2016, the United States Army removed its ban on women working in combat roles in previously reserved jobs for men. This policy change included a concerted effort by Army leadership to ensure women felt included in their new roles. Nevertheless, the immediate response to the policy changes led to mixed results in translating and implementing these new policies. This study takes qualitative data from a study on diversity and inclusion policy and practices to investigate women's experiences working in various roles in 2019. We collected qualitative data from 19 focus groups and 120 soldiers in 2019 from four Army installations across the United States. An inductive analysis of focus group interviews revealed three major themes: social exclusion due to gender, updated policies to include women, sexism, and gender harassment. Since inclusion is an interpersonal experience, the themes were analyzed through an intersectional template to see if race and rank also played a role in women's experiences in combat roles. These findings provide a more nuanced and lived experience perspective on being a woman serving in combat in the United States Army.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P